All content for Talks at GS is the property of Goldman Sachs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
"Talks at GS" convenes leading thinkers to share insights and ideas shaping the world.
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Talks at GS
"Talks at GS" convenes leading thinkers to share insights and ideas shaping the world.
